SEI Investments
ADVM

SEI Investments’s Adverum Biotechnologies ADVM Stock Holding History

SEI Investments’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,859
Closed -$388K – 2395
2020
Q2 		$388K Buy
+1,859
New +$329K ﹤0.01% 1963
2019
Q3 		– Sell
-4,491
Closed -$534K – 2365
2019
Q2 		$534K Buy
+4,491
New +$372K ﹤0.01% 1847
2017
Q2 		– Sell
-17
Closed – – 3047
2017
Q1 		$0 Hold
17
– – ﹤0.01% 2892
2016
Q4 		$1K Sell
17
-11
-39% -$359 ﹤0.01% 2768
2016
Q3 		$1K Buy
+28
New +$1.06K ﹤0.01% 2707
2015
Q4 		– Sell
-494
Closed -$41K – 2514
2015
Q3 		$41K Sell
494
-599
-55% -$76.5K ﹤0.01% 1951
2015
Q2 		$177K Buy
1,093
+680
+165% +$229K ﹤0.01% 1411
2015
Q1 		$167K Sell
413
-338
-45% -$143K ﹤0.01% 1456
2014
Q4 		$406K Buy
+751
New +$289K ﹤0.01% 1213

Other funds holding ADVM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

SEI Investments's ADVM Position: Q3 2020 in Review

SEI Investments sold out of Adverum Biotechnologies (ADVM) in Q3 2020, closing a stake of 1,859 shares — an estimated $388K sold.

SEI Investments first reported a position in ADVM in Q4 2014 and held it in 9 quarters. The position peaked at $534K in Q2 2019. 160 funds tracked by Wall St. Rank hold ADVM as of Q3 2020.

  • SEI Investments reported no remaining Adverum Biotechnologies position as of Q3 2020 after selling out during the quarter.
  • SEI Investments sold 1,859 Adverum Biotechnologies shares in Q3 2020, an estimated $388K.
  • SEI Investments first reported a position in Adverum Biotechnologies in Q4 2014 and held it in 9 quarters.
  • SEI Investments's Adverum Biotechnologies position peaked at $534K in Q2 2019.
  • 160 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2020.

Based on SEI Investments's 13F filing for Q3 2020, filed 6 Nov 2020.